Stay updated on Pembrolizumab Combo vs. Placebo in mCRPC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo vs. Placebo in mCRPC Clinical Trial page.

Latest updates to the Pembrolizumab Combo vs. Placebo in mCRPC Clinical Trial page
- Check5 days agoChange DetectedA new Revision: v3.3.3 entry was added to the history, and the HHS Vulnerability Disclosure and Revision: v3.3.2 items were removed from the footer.SummaryDifference0.2%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check27 days agoChange DetectedThe Study Record History shows a new Revision: v3.3.2 and removal of Revision: v3.3.1, indicating a minor UI/version update to the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check34 days agoChange DetectedRevision: v3.3.1 was added and Revision: v3.2.0 was removed from the history display.SummaryDifference0.1%

- Check41 days agoChange DetectedThe notice about government funding and operating status at the top of the page has been removed. No other content or functionality on the study record appears to have changed.SummaryDifference0.7%

- Check55 days agoChange DetectedScreenshots show only layout/style changes on the Record History page, with core study data such as status, arms, and outcomes unchanged; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check84 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference11%

Stay in the know with updates to Pembrolizumab Combo vs. Placebo in mCRPC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo vs. Placebo in mCRPC Clinical Trial page.